The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Am J Psychiatry 164:680-b-681, April 2007
doi: 10.1176/appi.ajp.164.4.680-b
© 2007 American Psychiatric Association
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via Google Scholar
Google Scholar
* Articles by HEATH, S.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by HEATH, S.
Related Collections
* Psychodynamic Therapy

Letter to the Editor

Reactive Depression and Remission Rates in the STAR*D Trials

SHELDON HEATH, M.D.
Toronto, Canada

To the Editor: The patient perspective in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study of lithium and T3 augmentation described a 44-year-old white female who became depressed after she lost her job (1). At one time such patients were diagnosed as having a reactive depression, with anger at what had happened being redirected at the self, causing both depression and later shame. The treatment was psychotherapy to release the anger and to help the patient regain a sense of self. The same dramatic result was described in the vignette, with the patient feeling as if her brain were "functioning again." This formulation is not without its critics. Some critics of this view would say that several weeks of psychotherapy may provide sufficient time for the disease to run its natural course, as opposed to any direct effect of the psychotherapy per se. Regardless of which view is correct, I wonder if some patients in the STAR*D trials might have suffered similar anger and shame and therefore not responded to drug therapy, which could partly explain the low remission rates observed.

Footnotes

Dr. Heath reports no competing interests.

References

  1. Nierenberg AA, Fava M, Trivedi MH, Wisniewski SR, Thase ME, McGrath PJ, Alpert JE, Warden D, Luther JF, Niederehe G, Lebowitz B, Shores-Wilson K, Rush AJ, STAR*D Study Team: A comparison of lithium and T3 augmentation following two failed medication treatments for depression: a STAR*D report. Am J Psychiatry 2006; 163:1519–1530[Abstract/Free Full Text]




This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via Google Scholar
Google Scholar
* Articles by HEATH, S.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by HEATH, S.
Related Collections
* Psychodynamic Therapy


Get information about faster international access.

Privacy Policy

Copyright © 2007 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org